Future Trials Conference: Decentralised, Direct to Patient and Virtual Clinical Research 2022

• Today’s trends and challenges in adoption
• Forecasts for the next generation of decentralised and digital clinical trials
• Opportunities for all to engage and avoid fear of being left behind

• A key to achieving the regulatory, ethical and scientific goals of any design strategy is listening to the voice of patients
• We’ll cover trends in listening to patients, how technology is creating data-driven insights into study-specific populations, and hear the voices of patients themselves
• Join this session to hear about the evolving role of patient voice in designing clinical trials

• Advanced technologies to maximize patient recruitment predictability at different
  stages
• Forecasting recruitment under different restrictions
• Optimal cost-efficient recruitment design, sites/countries selection
• Centralized statistical monitoring and detecting unusual data patterns
• Forecasting future recruitment performance
• Forecasting event counts in event driven trials (oncology, CRV)

• Explore some of the barriers and motivators for patients to participate in decentralized trials
• Understand the places you should consider getting patient input into the development process

• DCT overview – Pfizer’s definition and our hybrid strategy
• Our 5 priority modalities
• Challenges, Strategies, what we have Learned
• Q&A

• Understanding the patient’s need will help develop a comprehensive trial that will benefit both sides
• Outlining your patient scope and understand their trial preference (do they want to be on site or be part of the trial at home)
• Developing patient centric applications to help them upload their progress seamlessly

• Working on your relationship with your CRO so that concerns can be raised before they have a chance to negatively impact your trial
• Best practices in re-monitoring your data if needed in order to ensure that the data you have received is reliable
• The steps we should all be taking to cover ourselves in case the worst should happen and we are let down by our CRO

• Enhancing communication to Build workflows into patient visits so potential participants know there are trials available to them
• Building trust to understand the participants background, which helps develop an effective trial
• Taking extra time to review and understand where an individual’s biases may have impacted the design can greatly minimize the risk of creating a non-inclusive trial

• The usage data of virtual trial elements pre and post pandemic
• Identify how the utilization has evolved using various trial related metrics
• Looking to the future to analyze which elements will maintain, reduce or increase uptake in the coming years